Septic Shock News and Research

RSS

Prescriptive AI tools shift critical care toward personalized treatment.

Critical care requires rapid decisions from complex, evolving data. Predictive models forecast deterioration but do not guide therapy.

30 Oct 2026

Simple drug adjustment reduces kidney damage during septic shock surgery

A simple adjustment to drugs given during operations for septic shock could prevent thousands of patients suffering kidney damage, according to a major trial.

26 Oct 2026

Early vasopressin use does not improve septic shock survival

A new study from researchers at Intermountain Health in Salt Lake City found that starting an advanced medication earlier for critically ill patients with life-threatening septic shock does not improve their survival, shorten hospital stays, or improve their recovery compared with waiting until their condition potentially worsens.

14 Oct 2026

New national guidelines developed to improve sepsis-related care

A UVA Health doctor and other leading national experts have developed important new guidelines to improve care for patients who develop sepsis, a dangerous full-body infection that kills at least 350,000 Americans every year.

18 Sep 2026

More hospitals are adopting AI, yet the access gap is proving hard to close

A national analysis of 6,166 US hospitals found that specific workflow AI capabilities were associated with higher sepsis bundle completion rates and lower 30-day pneumonia mortality, whereas robotics showed narrower procedural associations. Geographic access remained highly uneven, with about 114.6 million people in the access-analysis population living more than 30 minutes from an AI-enabled hospital, although the observational design prevents causal conclusions.

14 Sep 2026

Researchers put olive and fish oil IV nutrition under the microscope

A systematic review of six randomized trials compared olive-oil-based and fish-oil-containing parenteral nutrition in hospitalized adults, examining infection, inflammation, oxidative stress, liver function, and clinical outcomes. The included studies involved diverse patient groups and lipid formulations, with substantial variation in outcomes and insufficient evidence for a meta-analysis.

18 Aug 2026

UH College of Pharmacy secures funding for three major health studies

University of Houston College of Pharmacy researchers have secured more than $1 million in new funding to support three separate studies targeting sepsis, Alzheimer's disease and related dementias, and depression in patients with sickle cell disease.

11 Aug 2026

NEWS2 score may improve antibiotic decisions in suspected sepsis

A study of nearly 100,000 adults treated for suspected infection suggests that the National Early Warning Score (NEWS2), a score based on routinely collected vital signs that is widely used to identify patients at risk of clinical deterioration, may help clinicians identify which patients are most likely to benefit from immediate antibiotic treatment and which may safely undergo further evaluation before receiving antibiotics.

6 Aug 2026

Bioresorbable sensor tracks deep-tissue lactate for over 10 days in animals

In animal models, the flexible implant captured local metabolic warning signs before selected systemic measurements and used them to guide earlier resuscitation.

27 Jul 2026

Collaborative AI system helps accelerate clinical trial design

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a new study by Weill Cornell Medicine investigators.

7 Jul 2026

Metformin reduces long COVID risk according to ACTIV-6 clinical trial

New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.

11 Jun 2026

Large clinical trial shows both common septic shock fluids are equal

A randomized clinical trial conducted across five countries in 47 pediatric emergency departments, including Ann & Robert H. Lurie Children's Hospital in Chicago, established that both commonly used IV fluids for treating septic shock – balanced crystalloid fluid and 0.9% saline – are equally safe and effective. Results were published in the New England Journal of Medicine.

5 Jun 2026

New AI tools identify potential drugs for rare Ebola virus

Recent advances in artificial intelligence have enabled Southwest Research Institute (SwRI) to identify nearly two dozen antiviral compounds that could potentially treat a rare species of Ebola virus (Bundibugyo virus) currently affecting the Democratic Republic of Congo.

26 May 2026

Study identifies protein essential for repairing damage after inflammation

Whenever there is a wound or infection, the body produces an inflammatory response. This is the body's first line of defense, and macrophages — cells of the innate immune system — play a key role: first, they help eliminate pathogens and other infectious agents, and then they trigger the mechanisms that repair the damage caused during the inflammatory process.

28 Apr 2026

Noninvasive brain monitoring reveals hidden oxygen deprivation in ICU patients

In neurological intensive care, it is quickly learned that the brain cannot wait. As the most sensitive organ in the human body, it can sustain irreversible damage after just a few minutes of severe hypoxia.

27 Apr 2026

Study finds different types of crystalloid fluids are equally effective for pediatric sepsis

A major study, led by researchers at Children's Hospital of Philadelphia, Nemours Children's Health, and Children's National Hospital and involving an extensive network of medical centers across the United States and abroad, found that different types of crystalloid fluid resuscitation were equally effective for staving off the most serious adverse kidney events after the treatment of pediatric patients with suspected septic shock.

25 Apr 2026